0000899243-21-036426.txt : 20210917 0000899243-21-036426.hdr.sgml : 20210917 20210917164339 ACCESSION NUMBER: 0000899243-21-036426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210917 FILED AS OF DATE: 20210917 DATE AS OF CHANGE: 20210917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harris Todd CENTRAL INDEX KEY: 0001711463 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 211260977 MAIL ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD STREET 2: SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-17 0 0001863127 Tyra Biosciences, Inc. TYRA 0001711463 Harris Todd C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 1 1 0 0 Chief Executive Officer Common Stock 2021-09-17 4 C 0 34007 A 1696343 D Series A Preferred Stock 2021-09-17 4 C 0 13093 0.00 D Common Stock 34007 0 D On September 17, 2021, each share of Series A Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. /s/ John Healy, Attorney-in Fact 2021-09-17